Home › Compare › ZONNF vs ABBV
ZONNF yields 8.08% · ABBV yields 3.06%● Live data
📍 ZONNF pulled ahead of the other in Year 1
Combined, ZONNF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZONNF + ABBV for your $10,000?
NOS, S.G.P.S., S.A. engages in the telecommunications, and media and entertainment business worldwide. It operates in Telco and Audiovisual segments. The company offers cable and satellite television, voice and internet access, mobile communication, IP voice, mobile virtual network, and related consulting services, as well as electronic communications services, including data and multimedia communications. It is also involved in the negotiation, acquisition, and distribution of content rights and other multimedia products, and Pay TV and video-on-demand rights; producing films and series channels; managing the advertising space on Pay TV channels; video production and sale; and cinema exhibition and distribution. In addition, the company provides data center management and consulting services in IT; invests in and supports the development of companies that aim to commercialize technologies and products; manages investments; commercializes public events; manages social participations in other companies; and offers accounting, logistics, administrative, financial, tax, human resources, and licensing and engineering services. Further, it engages in the design, construction, management, and exploitation of electronic communications networks, and equipment and infrastructure; management of technological assets and renders related services; achievement and promotion of scientific, and research and development activities; import, distribution, editing, commercialization, and production of audiovisual products; and provides demonstration, dissemination, technology transfer, and formation services in the field of services and information systems. Additionally, the company purchases, sales, rents, and operates property and commercial establishments; and manages real estate and financing activities. The company was founded in 1999 and is headquartered in Lisbon, Portugal. NOS, S.G.P.S., S.A. is a subsidiary of ZOPT, SGPS, S.A.
Full ZONNF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.